Abstract B041: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer

This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR010) of the Conference Program/Proceedings. Citation Format: Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese, Viridiana C...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research 2024-11, Vol.30 (21_Supplement), p.B041-B041
Main Authors: Sharifi, Marina N, Sperger, Jamie M, Taylor, Amy K, Tippins, Katharine E, Reese, Shannon R, Carreno, Viridiana, Kaufmann, Katherine R, Chang, Alex H, Nunamaker, Luke A, Linebarger, Charlotte, Helzer, Kyle T, Bootsma, Matthew, Blitzer, Grace C, Floberg, John, Kosoff, David, McKay, Rana R, Wei, Xiao X, Zhao, Shuang G, Lang, Joshua M
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This abstract is being presented as a short talk in the scientific program. A full abstract is printed in the Proffered Abstracts section (PR010) of the Conference Program/Proceedings. Citation Format: Marina N Sharifi, Jamie M Sperger, Amy K Taylor, Katharine E Tippins, Shannon R Reese, Viridiana Carreno, Katherine R Kaufmann, Alex H Chang, Luke A Nunamaker, Charlotte Linebarger, Kyle T Helzer, Matthew Bootsma, Grace C Blitzer, John Floberg, David Kosoff, Rana R McKay, Xiao X Wei, Shuang G Zhao, Joshua M Lang. High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancer [abstract]. In: Proceedings of the AACR Special Conference: Liquid Biopsy: From Discovery to Clinical Implementation; 2024 Nov 13-16; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2024;30(21_Suppl):Abstract nr B041.
ISSN:1557-3265
1557-3265
DOI:10.1158/1557-3265.LIQBIOP24-B041